Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Oyster Point Pharma, Inc. (OYST)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 |
| Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Inventory turnover | 0.5 | | | | | |
Asset turnover | 0.1 | 0.0 | 0.0 | 0.0 | | |
|
Returns on Capital |
ROIC (excluding intangibles) | -1372.6% | -1480.1% | -1746.1% | | | |
ROIC (including intangibles) | -955.9% | -1787.1% | -841.6% | 8260.6% | | 6425.1% |
ROE | -97.1% | -38.0% | -34.5% | -351.7% | | -26.9% |
ROA | -43.4% | -35.9% | -33.0% | -293.4% | | -24.5% |
|
Cash Conversion Cycle |
Days sales outstanding | 99.0 | | | | | 0.0 |
Days payables outstanding | 1,554.8 | | | | | 26.8 |
Days inventory outstanding | 1,456.6 | | | | | |
Cash conversion cycle | 0.9 | | | | | -26.8 |
|